. Ondansetron is more effective than metoclopramide for the treatment of opioidinduced emesis in post surgical adult patients. 
Introduction movement [1, 2] . Opioids are commonly used in the post-surgical setting for pain management and are Ondansetron is a highly effective anti-emetic indicated recognised as an important component of the emfor use for chemotherapy/radiotherapy-induced emetogenic stimulus [3] . As a result of emetic side effects, esis (CRIE) (Rung et al.[12] ). For this study, it was estimated patients receiving a range of surgical interventions (see Table 1 During the 6 h post-treatment study period, ondansetron at both doses produced highly effective this was achieved using the procedure proposed by Hochberg [13] . Assuming 450 patients in each treatanti-emetic activity and these were significantly more effective than metoclopramide (P < 0.001, Fig. 1 (8 mg and 16 mg) and metoclopramide (10 mg) rather than the unpleasant side effects of nausea and during the 24 h post-treatment study period emesis/vomiting associated with these drugs [17] .
Opioid [18] [19] [20] [21] [22] [23] [24] . In addition to the OIE element, many factors could occurring post-treatment was similar across all three [12] [27, 28] ' Soc J 1976; 23: dansetron is the first anti-emetic for which efficacy in 366-369. OIE has been formally assessed. 
